Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Isatuximab’s On-Body Delivery System (Sub-q)- IRAKLIA Trial | Claudio Cerchione, MD | #IMS2025
HealthTreeDescription
In this #IMS2025 interview, Claudio Cerchione, MD, discusses the IRAKLIA study evaluating the use of on-body isatuximab injection for patients with multiple myeloma. Learn how this new delivery method may simplify treatment, improve convenience, and reduce time in the clinic while maintaining efficacy.
👉 Stay updated on the latest in myeloma research and innovation from IMS 2025.
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.